EXECUTIVE SUMMARY — Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, ActivinE — Leading key opinion leaders (KOLs) Drs. Jason Fung, Scott Kahan, Lawrence Cheskin, and Lee Kaplan from leading institutions such as Johns Hopkins, GMU, and Dartmouth University respectively shared their insights on challenges with […]

AUSTIN, TX / ACCESS Newswire / December 16, 2025 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it has achieved SOC 2 type I compliance through a third-party audit of its information security and privacy controls. Compliance with SOC 2’s high standards reflects Babson

Blake C.McCall, founder of Blake Charles Salon, announces the acquisition of the esteemed Salon Le Boudoir in Saint-Tropez, France. This milestone marks Blake Charles Salon's official expansion into Europe, bringing the sophistication of San Francisco to the timeless beauty of the French Riviera. https://mma.prnewswire.com/media/2847038/Christophe_Owner_of_Le_Boudior_and_Blake_Charles.jpg Blake Charles Salon is recognized as one of the most celebrated

Rosalind Franklin University's Innovation and Research Park (IRP) is now home to the new Northern Illinois Laboratory for Tolmar, Inc.(Tolmar), a specialty pharmaceutical company. The new center expands Tolmar's capacity for developing and commercializing pharmaceutical products, while deepening the university's ecosystem of industry innovation. https://mma.prnewswire.com/media/1076585/RFU_Logo.jpg Founded in 2007, Tolmar is a pharmaceutical company recognized internationally

Toronto, Ontario–(Newsfile Corp. – Le 16 décembre/December 2025) – Trading in the shares of Cypher Metaverse Inc. (CODE.X) will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant to CSE Policy 8. This regulatory halt is imposed by Canadian Investment Regulatory Organization, the Market Regulator of the Exchange, pursuant to

Montreal, Quebec–(Newsfile Corp. – December 16, 2025) – Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) ("Amex" or "the Company") is pleased to announce the closing of its acquisition (the "Transaction") of a 100% undivided interest in the 324 non-contiguous mining claims comprising 8,392.92 hectares in the Abbotsford and Hepburn Townships in the province of Ontario. The

(NASDAQ:FMAO), ARCHBOLD, Ohio, Dec. 16, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO) the holding company of F&M Bank, with total assets of $3.39 billion at September 30, 2025, today announced that it has approved the Company's quarterly cash dividend of $0.23 per share. The fourth-quarter dividend

Farmers & Merchants Bancorp, Inc. Declares 2025 Fourth-Quarter Cash Dividend Regular quarterly dividend increased 4.0% year-over-year to $0.23 per share GlobeNewswire December 16, 2025 ARCHBOLD, Ohio, Dec. 16, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO) the holding company of F&M Bank, with total assets of $3.39

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline. So what: If you purchased Stride securitiesduring the Class Period you may

Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology today announced an update on the INBRX-106 Phase 2/3 clinical trial in combination with Keytruda® (pembrolizumab) as a first-line treatment for patients with locally advanced unresectable or metastatic head and neck squamous cell carcinoma (HNSCC) and